Fischer_et_al_2022_Supplemental_Data

Figshare2022-03-03 更新2026-04-28 收录

结直肠癌分子机制

PLAGL2基因功能

数据链接：

https://figshare.com/articles/dataset/Fischer_et_al_2022_Supplemental_Data/19299809 数据链接链接失效反馈

官方服务：

资源简介：

Raw data accompanying Fischer et. al. 2022 paper entitled "The oncogenic function of PLAGL2 is mediated via specific target genes through a Wnt-independent mechanism in colorectal cancer".

创建时间：

2022-03-03

Expression profiling of HCT116 cells transfected with shCTRL or shKSR1

结直肠癌分子机制

基因表达谱分析

We engineered HCT116 cells by transfecting a non targeting control hairpin or 2 different short hairpin against KSR1 to knockdown KSR1 and microarrays were performed on non-transfected controls, non-t

NIAID Data Ecosystem60

The Chromatin Remodeler Chromodomain Helicase DNA Binding Protein 2 Promotes Colorectal Cancer Progression

结直肠癌分子机制

癌症生物标志物

Integrative analysis of colorectal cancer (CRC) whole genomes and matched transcriptomes revealed that somatic promoter mutations are associated with increased Chromodomain helicase DNA-binding protei

NIAID Data Ecosystem30

Vitamin D Receptor Deficiency Enhances Wnt/β-Catenin Signaling and Tumor Burden in Colon Cancer

结直肠癌分子机制

Wnt/β-catenin信号通路

Aberrant activation of the Wnt/β-catenin pathway is critical for the initiation and progression of most colon cancers. This activation provokes the accumulation of nuclear β-catenin and the induction

NIAID Data Ecosystem30

Data_Sheet_2_MiR-490-3p Silences CDK1 and Inhibits the Proliferation of Colon Cancer Through an LLPS-Dependent miRISC System.PDF

结直肠癌分子机制

液-液相分离

Liquid-liquid phase separation (LLPS) is a burgeoning concept in cell biology, which was associated with miRISC machinery. However, most studies about LLPS are based on overexpression of core proteins

NIAID Data Ecosystem40

Supporting Information S1 - Rosiglitazone and AS601245 Decrease Cell Adhesion and Migration through Modulation of Specific Gene Expression in Human Colon Cancer Cells

结直肠癌分子机制

药物基因表达

List of genes up-regulated and down-regulated at 24 hours, by 50 µM rosiglitazone, 0.1 µM AS601245 and combined treatment. Values represent P-values and fold changes versus 1% DMSO-treated CaCo-2 cell

NIAID Data Ecosystem30

Fischer_et_al_2022_Supplemental_Data

资源简介：

相关数据集